Thank you for your interest in the Brigance Brigade Foundation’s PALS Grant Program. All applications should be completed, signed, and sent to grants@brigancebrigade.org
Our Board PALS Grant Committee meets twice a year to assess available funds, review active applications and award grants. We recognize that there is a critical need for financial assistance in the ALS community and we will prioritize notifying PALS, CALS, and advocates of grant award decisions via email as awards are granted.
Cycle 1: March 1, 2026 – May 31, 2026 I Cycle 2: September 1, 2026 – November 30, 2026
To apply, please ensure your application is complete, including all required attachments and official quotes.
First-time applicants will be reviewed in the order received, while funding is available.
Re-applicants can apply, but their submissions will be reviewed at a later date, depending on available funding after first-time applicants are awarded.
The PALS Grant Program provides financial grants to People living with ALS (PALS) and their families to help offset some of the staggering costs associated with ALS. We are dedicated to increasing access to caregiving services, equipment and home modifications for accessibility for people living with ALS.
Each PALS Grant Program applicant is eligible for one PALS Grant Program award per calendar year with a max financial award of $5,000. Grant applicants may mix and match support categories to best fit their needs. For more information, please see the worksheet enclosed in the PALS Grant Program application.
*BBF will continue to prioritize first-time grant seekers. Those who have been previously awarded a BBF PALS Grant, and meet the geographic requirements for applicants, may be eligible should funds be available at the end of the calendar year.
The Brigance Brigade Foundation directly serves ALS families with access to critical financial grants and equipment, not covered by insurance. While we are proud to have helped hundreds of families, it’s never enough. Out-of-pocket costs can be upwards of $200,000 annually and over 31,000 people are currently living with the disease in the U.S.
